TY  - JOUR
AU  - Estes, Chris
AU  - Anstee, Quentin M
AU  - Arias-Loste, Maria Teresa
AU  - Bantel, Heike
AU  - Bellentani, Stefano
AU  - Caballeria, Joan
AU  - Colombo, Massimo
AU  - Craxi, Antonio
AU  - Crespo, Javier
AU  - Day, Christopher P
AU  - Eguchi, Yuichiro
AU  - Geier, Andreas
AU  - Kondili, Loreta A
AU  - Kroy, Daniela C
AU  - Lazarus, Jeffrey V
AU  - Loomba, Rohit
AU  - Manns, Michael P
AU  - Marchesini, Giulio
AU  - Nakajima, Atsushi
AU  - Negro, Francesco
AU  - Petta, Salvatore
AU  - Ratziu, Vlad
AU  - Romero-Gomez, Manuel
AU  - Sanyal, Arun
AU  - Schattenberg, Jörn M
AU  - Tacke, Frank
AU  - Tanaka, Junko
AU  - Trautwein, Christian
AU  - Wei, Lai
AU  - Zeuzem, Stefan
AU  - Razavi, Homie
PY  - 2018
DO  - 10.1016/j.jhep.2018.05.036
UR  - http://hdl.handle.net/10668/12569
T2  - Journal of hepatology
AB  - Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are increasingly a cause of cirrhosis and hepatocellular carcinoma globally. This burden is expected to increase as epidemics of obesity, diabetes and metabolic...
LA  - en
KW  - Burden of disease
KW  - Cardiovascular disease
KW  - Cirrhosis
KW  - Diabetes mellitus
KW  - HCC
KW  - Health care resource utilization
KW  - Metabolic syndrome
KW  - NAFLD
KW  - NASH
KW  - Obesity
KW  - China
KW  - Cost of Illness
KW  - Diabetes Mellitus, Type 2
KW  - Humans
KW  - Liver Diseases
KW  - Markov Chains
KW  - Models, Theoretical
KW  - Non-alcoholic Fatty Liver Disease
KW  - Obesity
KW  - Prevalence
KW  - Time Factors
TI  - Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030.
TY  - research article
VL  - 69
ER  -